Shimada H - Search Results

1

Population pharmacokinetic analysis of esomeprazole in Japanese subjects with various CYP2C19 phenotypes.

Nagase M, Shimada H, Nii M, Ueda S, Higashimori M, Ichikawa K, Zhang L, Zhou L, Chen Y, Zhou D, Dunyak J, Al-Huniti N. Nagase M, et al. Among authors: shimada h. J Clin Pharm Ther. 2020 Oct;45(5):1030-1038. doi: 10.1111/jcpt.13129. Epub 2020 Mar 30. J Clin Pharm Ther. 2020. PMID: 32227647

2

Physiologically based pharmacokinetic modeling to predict exposures in healthy Japanese subjects with different CYP2C19 phenotypes: Esomeprazole case study .

Higashimori M, Shimada H, Ichikawa K, Zhou D. Higashimori M, et al. Among authors: shimada h. Int J Clin Pharmacol Ther. 2020 Jan;58(1):29-36. doi: 10.5414/CP203488. Int J Clin Pharmacol Ther. 2020. PMID: 31657713

3

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of an Omega-3-Carboxylic Acid Formulation in Healthy Male Japanese Subjects: A Phase 1 Single-Blind, Randomized, Placebo-Controlled Trial.

Noda Y, Nilsson C, Shimada H, Kim H, Lundström T, Yajima T. Noda Y, et al. Among authors: shimada h. Clin Pharmacol Drug Dev. 2018 Feb;7(2):177-187. doi: 10.1002/cpdd.360. Epub 2017 Jun 9. Clin Pharmacol Drug Dev. 2018. PMID: 28597973 Clinical Trial.

4

Effects of Food on the Pharmacokinetics of Omega-3-Carboxylic Acids in Healthy Japanese Male Subjects: A Phase I, Randomized, Open-label, Three-period, Crossover Trial.

Shimada H, Nilsson C, Noda Y, Kim H, Lundström T, Yajima T. Shimada H, et al. J Atheroscler Thromb. 2017 Sep 1;24(9):980-987. doi: 10.5551/jat.38737. Epub 2017 Mar 24. J Atheroscler Thromb. 2017. PMID: 28344197 Free PMC article. Clinical Trial.

5

First report of the safety, tolerability, and pharmacokinetics of the Src kinase inhibitor saracatinib (AZD0530) in Japanese patients with advanced solid tumours.

Fujisaka Y, Onozawa Y, Kurata T, Yasui H, Goto I, Yamazaki K, Machida N, Watanabe J, Shimada H, Shi X, Boku N. Fujisaka Y, et al. Among authors: shimada h. Invest New Drugs. 2013 Feb;31(1):108-14. doi: 10.1007/s10637-012-9809-7. Epub 2012 Mar 14. Invest New Drugs. 2013. PMID: 22415795 Clinical Trial.

6

Pharmacokinetics, Pharmacodynamics, and Tolerability of AZD5718, an Oral 5-Lipoxygenase-Activating Protein (FLAP) Inhibitor, in Healthy Japanese Male Subjects.

Knöchel J, Nelander K, Heijer M, Lindstedt EL, Forsberg GB, Whatling C, Shimada H, Han DS, Gabrielsen A, Garkaviy P, Ericsson H. Knöchel J, et al. Among authors: shimada h. Clin Drug Investig. 2021 Oct;41(10):895-905. doi: 10.1007/s40261-021-01078-7. Epub 2021 Sep 21. Clin Drug Investig. 2021. PMID: 34546534 Free PMC article. Clinical Trial.

7

Safety and tolerability of selumetinib as a monotherapy, or in combination with docetaxel as second-line therapy, in Japanese patients with advanced solid malignancies or non-small cell lung cancer.

Seto T, Hirai F, Saka H, Kogure Y, Yoh K, Niho S, Fukase K, Shimada H, Sasai M, Fukino K. Seto T, et al. Among authors: shimada h. Jpn J Clin Oncol. 2018 Jan 1;48(1):31-42. doi: 10.1093/jjco/hyx144. Jpn J Clin Oncol. 2018. PMID: 29136201 Clinical Trial.

8

Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I study.

Asahina H, Nokihara H, Yamamoto N, Yamada Y, Tamura Y, Honda K, Seki Y, Tanabe Y, Shimada H, Shi X, Tamura T. Asahina H, et al. Among authors: shimada h. Invest New Drugs. 2013 Jun;31(3):677-84. doi: 10.1007/s10637-012-9860-4. Epub 2012 Jul 28. Invest New Drugs. 2013. PMID: 22843211 Clinical Trial.

9

Imaging α-synuclein pathologies in animal models and patients with Parkinson's and related diseases.

Endo H, Ono M, Takado Y, Matsuoka K, Takahashi M, Tagai K, Kataoka Y, Hirata K, Takahata K, Seki C, Kokubo N, Fujinaga M, Mori W, Nagai Y, Mimura K, Kumata K, Kikuchi T, Shimozawa A, Mishra SK, Yamaguchi Y, Shimizu H, Kakita A, Takuwa H, Shinotoh H, Shimada H, Kimura Y, Ichise M, Suhara T, Minamimoto T, Sahara N, Kawamura K, Zhang MR, Hasegawa M, Higuchi M. Endo H, et al. Among authors: shimada h. Neuron. 2024 May 27:S0896-6273(24)00332-5. doi: 10.1016/j.neuron.2024.05.006. Online ahead of print. Neuron. 2024. PMID: 38843838

10

Diversity in productive activities enhances life satisfaction among Japanese community-dwelling older adults: A cross-sectional study.

Fujii K, Lee S, Katayama O, Makino K, Harada K, Tomida K, Morikawa M, Yamaguchi R, Nishijima C, Misu Y, Shimada H. Fujii K, et al. Among authors: shimada h. Geriatr Nurs. 2024 Jun 4;58:232-237. doi: 10.1016/j.gerinurse.2024.05.033. Online ahead of print. Geriatr Nurs. 2024. PMID: 38838405

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,284 results

Search Page